PO-1242 Clinical, pathological and dosimetric factors influencing outcomes in NSCLC treated with SABR. (May 2022) - Padden-Modi, M.; Spivak, Y.; Gleeson, I.; Robinson, A.; Thippu Jayaprakash, K.